TG Therapeutics Inc (TGTX)

Cash ratio

Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Cash and cash equivalents US$ in thousands 195,822 82,910 75,477 92,933 150,902 97,009 61,469 102,304 109,860 147,073 185,676 298,887 326,512 401,707 471,514 553,439 254,154 260,512 52,051 112,637
Short-term investments US$ in thousands 145,219 134,342 134,308 124,575 78,257 47,896 78,241 59,374 66,082 48,636 47,525 15,876 30,338 41,752 52,334 51,987 46 15,058 26,284 27,798
Total current liabilities US$ in thousands 125,114 108,664 99,684 53,720 57,678 72,667 63,076 53,201 36,447 43,326 54,656 65,384 87,655 87,551 92,494 87,554 77,670 67,537 63,118 84,449
Cash ratio 2.73 2.00 2.10 4.05 3.97 1.99 2.21 3.04 4.83 4.52 4.27 4.81 4.07 5.07 5.66 6.91 3.27 4.08 1.24 1.66

September 30, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($195,822K + $145,219K) ÷ $125,114K
= 2.73

The cash ratio of TG Therapeutics Inc has shown some fluctuations over the past few quarters. The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents.

Looking at the data, the cash ratio has generally been above 1, indicating that the company has sufficient cash to cover its short-term obligations. The cash ratio has ranged from 1.24 to 6.91 over the past few years, with the highest values indicating a stronger ability to meet short-term obligations with cash on hand.

Specifically, the cash ratio increased from 1.66 in March 2020 to 6.91 in December 2020, showing a significant improvement in liquidity. However, there were fluctuations in the subsequent quarters, with the ratio ranging between 2.00 and 4.83.

Overall, the cash ratio of TG Therapeutics Inc suggests that the company has generally maintained a healthy level of liquidity, enabling it to meet its short-term obligations comfortably.


Peer comparison

Sep 30, 2024